US 12221460
Antibody drug conjugates
granted A61KA61K2039/505A61K31/7084
Quick answer
US patent 12221460 (Antibody drug conjugates) held by Takeda Pharmaceutical Company Limited expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K31/7084, A61K39/39558, A61K47/6807